Literature DB >> 1857968

Deleted HTLV-I provirus in blood and cutaneous lesions of patients with mycosis fungoides.

W W Hall1, C R Liu, O Schneewind, H Takahashi, M H Kaplan, G Röupe, A Vahlne.   

Abstract

Mycosis fungoides, a rare form of cutaneous T cell leukemia/lymphoma, is suspected of having a viral etiology on the basis of certain similarities to adult T cell leukemia, which is associated with human T cell leukemia/lymphoma virus type I (HTLV-I) infection. Cell lines were established from peripheral blood mononuclear cells (PBMC) of an HTLV-I-seronegative patient with mycosis fungoides. DNA hybridization analysis revealed the presence of HTLV-I-related sequences with unusual restriction endonuclease sites. Sequence analysis of subcloned fragments demonstrated the presence of a monoclonally integrated provirus with a 5.5-kilobase deletion involving large regions of gag and env and all of pol. Additional evidence for the presence of deleted proviruses was found by polymerase chain reaction (PCR) amplification of DNA from cutaneous lesions of five other HTLV-I-seronegative patients. The findings suggest that HTLV-I infection may be involved in the etiology of at least certain cases of mycosis fungoides.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1857968     DOI: 10.1126/science.1857968

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  22 in total

Review 1.  Cutaneous lymphoproliferative disorders: strategies for molecular biological analysis and their major findings.

Authors:  G S Wood
Journal:  Springer Semin Immunopathol       Date:  1992

2.  Transmission of human T-cell lymphotropic virus type 1 tax to rabbits by tax-only-positive human cells.

Authors:  D Zucker-Franklin; B A Pancake; P Lalezari; M Khorshidi
Journal:  Clin Diagn Lab Immunol       Date:  2000-03

3.  Physical and functional interaction between the human T-cell lymphotropic virus type 1 Tax1 protein and the CCAAT binding protein NF-Y.

Authors:  C A Pise-Masison; J Dittmer; K E Clemens; J N Brady
Journal:  Mol Cell Biol       Date:  1997-03       Impact factor: 4.272

4.  No evidence of HTLV-I proviral integration in lymphoproliferative disorders associated with cutaneous T-cell lymphoma.

Authors:  G S Wood; J M Schaffer; R Boni; R Dummer; G Burg; M Takeshita; M Kikuchi
Journal:  Am J Pathol       Date:  1997-02       Impact factor: 4.307

5.  Reexamination of human T cell lymphotropic virus (HTLV-I/II) prevalence.

Authors:  D Zucker-Franklin; B A Pancake; M Marmor; P M Legler
Journal:  Proc Natl Acad Sci U S A       Date:  1997-06-10       Impact factor: 11.205

6.  High frequencies of human T-lymphotropic virus type I (HTLV-I) infection and presence of HTLV-II proviral DNA in blood donors with anti-thyroid antibodies.

Authors:  H Mine; H Kawai; K Yokoi; M Akaike; S Saito
Journal:  J Mol Med (Berl)       Date:  1996-08       Impact factor: 4.599

7.  Interleukin-7 is a growth factor for Sézary lymphoma cells.

Authors:  A Dalloul; L Laroche; M Bagot; M D Mossalayi; C Fourcade; D J Thacker; D E Hogge; H Merle-Béral; P Debré; C Schmitt
Journal:  J Clin Invest       Date:  1992-09       Impact factor: 14.808

8.  Detection of human T-lymphotropic virus-like particles in cultures of peripheral blood lymphocytes from patients with mycosis fungoides.

Authors:  D Zucker-Franklin; E E Coutavas; M G Rush; D C Zouzias
Journal:  Proc Natl Acad Sci U S A       Date:  1991-09-01       Impact factor: 11.205

9.  Activation of the human T-cell leukemia virus type I enhancer is mediated by binding sites for Elf-1 and the pets factor.

Authors:  N M Clark; M J Smith; J M Hilfinger; D M Markovitz
Journal:  J Virol       Date:  1993-09       Impact factor: 5.103

10.  Human T-cell lymphotropic virus type 1 tax among American blood donors.

Authors:  D Zucker-Franklin; B A Pancake
Journal:  Clin Diagn Lab Immunol       Date:  1998-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.